Filing Details

Accession Number:
0001610717-23-000419
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-22 16:10:48
Reporting Period:
2023-12-20
Accepted Time:
2023-12-22 16:10:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501989 Cytomx Therapeutics Inc. CTMX Pharmaceutical Preparations (2834) 273521219
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1914523 Christopher Ogden C/O Cytomx Therapeutics, Inc.
151 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
Svp, Finance And Accounting No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-12-20 1,990 $1.38 48,657 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
  2. Includes 30,466 restricted stock units.